Sonja Jamsek took a mild dose of Lexapro during her pregnancy. Her doctor warned that her infant might experience withdrawal after being born.
However, the doctor didn’t advise that her infant may develop Persistent Pulmonary Hypertension of the Newborn (PPHN). At the time, her doctor was unaware of this particular Lexapro birth defect.
Sonja Jamsek alleges that Lexapro is to blame for pulmonary hypertension in her baby. She argues that PPHN limited her daughter’s oxygen supply and caused fatal internal bleeding.
It’s a drug company’s responsibility to inform physicians and patients about all known risks involved in taking medication. When they don’t, they must be held accountable for damages.
Over the last decade, Carey Danis & Lowe attorneys have obtained over $1 billion in compensation on behalf of clients in cases against manufacturers of harmful pharmaceutical products.
Our St. Louis law firm assists families whose lives have been turned upside down because of Lexapro birth defects.
If your newborn developed a birth defect as a result of exposure to Lexapro in the womb, you may be entitled to receive compensation.
Our experienced Lexapro lawyers can assist you in exploring your legal options in a free consultation.
Please call Carey Danis & Lowe today at 800.721.2519, or email us.References: Pharmaceutical litigation